All News

RN.podcast.resized.jpg

RheumNow Podcast- A Good First Impression (1.24.20)

d Jack Cush, MD

Dr Jack Cush comments on this week's journal articles, reviews and studies.

Read Article
QD%20Video_2.jpg

QD Clinic - "Doc, When Can I Stop?"

d Jack Cush, MD

QD Clinic - Lessons from the clinic. In this video: Patients stable on a biologic need guidance on when, and if, they can stop their biologic.

Read Article
hidradenitis.jpg

Low Risk of Inflammatory Arthritis in Hidradenitis Suppurativa Patients

d Jack Cush, MD

JAMA Dermatology reports that after the onset and diagnosis of hidradenitis suppurativa (HS), such patients have a higher risk of certain forms inflammatory arthritis.

Read Article
The RheumNow Podcast is up! This week: what happens before PsA; DASH diet and urate; and are RA patient reported Flares valid? Check out the videocast https://t.co/JDbYOiMYvU or listen to the podcast on iTunes or SoundCloud https://t.co/nK6l6z39fR

Links:

Dr. John Cush RheumNow ( View Tweet)

Article on Yahoo about "7 Red Flags You Need a New Rheumatologist" 1 )When they discourage your own research 2) Don’t believe you 3) Bad info on health insurance 4) Rx everyone the same 5) Dx by lab results 6 ) No questions allowed 7) "nothing I can do” https://t.co/KMQNKnADBM

Links:

Dr. John Cush RheumNow ( View Tweet)

New EULAR 2019 Rheumatoid Arthritis Treatment recommendations are out. Rheumatologists are the specialists who should care for RA; decisions are based on disease activity, safety issues and other patient factors (comorbidities) https://t.co/4NwYcR8l8G

Links:

Dr. John Cush RheumNow ( View Tweet)

#MLK - "No person has the right to rain on your dreams" Martin Luther King, Jr.

Dr. John Cush RheumNow ( View Tweet)

Health Care Utilization prior to the Dx of Psoriatic Arthritis #PsA is significantly 2 fold higher. Study of 462 PsA & 2310 comparators shows more visits to PCP for MSK issues in 1-5 yrs prior, as well as use of other MSK specialists in 5 yrs preceding Dx. https://t.co/5729ya9Ahr

Links:

Dr. John Cush RheumNow ( View Tweet)

Data from the Swedish Rheumatology Quality register (2716 RA pts) shows that biologic naive patients had longer drug survival. Men (HR 0.86) and MTX users (HR 0.85) were less likely to discontinue abatacept, https://t.co/Vhy3XtEg8R

Links:

Dr. John Cush RheumNow ( View Tweet)

Fantastic article from @HealioRheum detailing the history and the hard work of CSRO. With phenomenal leaders like Dr. Michael Schweitz and @MattieRheumMD, CSRO will continue to effectively advocate for high-quality rheumatology care at an affordable rate! https://t.co/ImA9aeaXqh
CSRO CSROAdvocacy ( View Tweet)

#UTSW Dr Nicole Bittencourt on fever and autoinflammatory workup. Here are sources for genetic testing. I rec the Invitae autoinflammatory panel (or cash pay ~$100) https://t.co/XsJ0k7q0ex

Dr. John Cush RheumNow ( View Tweet)
60% The percentage of patients at @NIH's autoinflammatory disease cohort that are undifferentiated and do not have a specific disease diagnosis -Dr. Amanda Ombrello. #ACR19 @rheumnow https://t.co/d85OtnEA8o
Jonathan Hausmann MD hausmannMD ( View Tweet)
In 80 RA pts, SJC & TJC flares seen in 36% of pts. Pt-reported flares usually reflected incr Dz activity (MD exam & US). Pts & clinicians agreed in 79–93% of joints, moreso SJ than TJ. Using US, there was high specificity (>86%) & low sensitivity (<34%) https://t.co/jMRQg5fUuS

Links:

Dr. John Cush RheumNow ( View Tweet)

#UTSW Dr Lauren Nassi on JIA - enthesitis related arthropathy or ERA. 80% are B27+. May develop AS or SpA much later. They respond very well to TNF inhibitors

Dr. John Cush RheumNow ( View Tweet)

#UTSW Dr Lauren Nassi on JIA - long term outcomes in Oligoarticular jia is not so benign. Half go on to polyarticular disease https://t.co/eRv52dtyZY
Dr. John Cush RheumNow ( View Tweet)
#UTSW Dr Lauren Nassi on JIA- red flags with Oligoarticular JIA Painful joint Hip involvement High acute phase reactants

Dr. John Cush RheumNow ( View Tweet)

#UTSW Rheum GR Rounds Dr Lauren Nassi on JIA - JIA accounts for 50-70% of all cases in a pediatric rheum clinic

Dr. John Cush RheumNow ( View Tweet)

#MLK - "We may have all come on different ships; but we’re in the same boat now” Martin Luther King, Jr.

Dr. John Cush RheumNow ( View Tweet)

#MLK - “We will remember not the words of our enemies, but the silence of our friends.” Martin Luther King, Jr.

Dr. John Cush RheumNow ( View Tweet)

IL-37 may be a target for psoriasis. IL-37 is downregulated in lesional skin & IL-37 serum levels correlate with psoriasis severity. IL-37 is an anti-inflammatory & immunosuppressive cytokine from IL-1 family. Tofacitinib may increase IL-37 in psoriasis https://t.co/jPaGlcDFV2

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×